PHIA Koninklijke Philips N.V.

Philips integrates AI in cardiac ultrasound and across cardiac care at ESC 2023

Philips integrates AI in cardiac ultrasound and across cardiac care at ESC 2023

August 24, 2023

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how it integrates AI in cardiac ultrasound and across cardiac care to help improve clinical confidence and increase efficiency. Center-stage at the European Society of Cardiology (, Aug. 25-28, Amsterdam) Congress is the portable , which includes an AI-powered automation tool (the automated strain quantification) to assess the function of the heart’s left ventricle, a key indicator of heart health.

“The demands on cardiology departments have never been higher, driving clinicians to balance the delivery of high-quality care for a growing volume of complex patients with pressures to improve departmental efficiency,” said , Executive Vice President and Chief Business Leader of Image Guided Therapy and Precision Diagnosis at Philips. “From helping sonographers acquire the right image and analyze it in the right way, to cutting the assessment time for cardiac MR and CT images, we’re integrating AI across our portfolio to help clinicians make sense of all the information available to them so that they can focus more on caring for their patients.”

Integrating AI in cardiac ultrasound

Ultrasound is one of the most used imaging modalities as the first line of diagnosis for cardiac patients. A shortage of operators dealing with heavy workloads and growing numbers of complex cases continues to challenge health systems across the globe. Using AI to help streamline workflows and enhance diagnostic confidence is core to Philips cardiac ultrasound technology. Each year, Philips’ ultrasound systems support the diagnosis and treatment of more than 240 million patients.

Philips is a leader in integrating AI-powered technology across its , including full 3D quantification and modeling of the heart, automated 2D Doppler and length measurements, reproducible 2D strain quantification and dynamic analysis of the mitral valve. The company is now integrating AI-powered automated analysis and reporting.  

Integrating AI across cardiac care

Individually, Philips’ solutions can help solve cardiology’s daily challenges. Together, they create a powerful ecosystem that helps clinicians realize better cardiac care with greater efficiency. At ESC, Philips will also highlight its , which integrates AI-enabled algorithms and workflows into a single workspace. The integration of Cardiac MR and CT on Philips Advanced Visualization Workspace has lowered overall analysis time by 20-30% [1].

Philips monitors 1.2 million patients every year, with 4 billion heartbeat data transmissions daily [2]. Philips cardiology management solutions include remote cardiac monitoring innovations from , a leading AI-powered remote ambulatory cardiac monitoring provider, to better manage heart patients by extending physicians’ diagnostics  and cardiac monitoring from home to hospital – and hospital to home.

Visit (Hall 1, booth #A300) for more information on Philips’ entire program at the event, including a satellite symposium featuring global clinical leaders addressing some of the major challenges in peri-interventional and diagnostic echocardiography and a wide range of hands-on tutorial sessions. Follow for #ESCCongress updates throughout the event.

[1] Dr. Gaby Weissman, MD MedStar Washington Hospital Center, Washington, D.C., USA

[2] Data on file

For further information, please contact:

Mark Groves

Philips Global Press Office

Tel.:

E-Mail:   

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 71,500 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
24/08/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new...

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member April 2, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Carla Goulart Peron, MD, Chief Medical Officer at Philips, has been appointed to the of the Medical Device Innovation Consortium (). Founded in 2012, MDIC is a unique public-private partnership that brings stakeholders across the medical device spectrum together with the US Food and Drug Administration () and other agency partners to help ensure patient access to medical device inn...

 PRESS RELEASE

FDA clears Philips AI solution that provides real-time guidance during...

FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates with Philips Azurion image-guided therapy platform that combines imaging, real-time data and intelligent software within a unified workflow to support more consistent, efficient and confidently guided minimally invasive procedures Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA...

 PRESS RELEASE

Philips launches IntraSight Plus to simplify coronary interventions an...

Philips launches IntraSight Plus to simplify coronary interventions and advance precision care March 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient careWith FDA clearance and CE marking, IntraSight Plus streamlines the workflow efficiency of minimally invasive coronary procedures and can enable system operation time savings up to 47% in both the USA and Europe Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technolog...

 PRESS RELEASE

Philips remains No. 1 in Medtech at European Patent Office and the lar...

Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips’ platform-based solutions integrate hardware, software, data and AI to address clinical, operational and everyday health challenges.Philips’ innovation improved the lives of 2 billion people in 2025, with the goal of improving 2.5 billion lives per year by 2030, including 400 million people in medically unde...

 PRESS RELEASE

Philips convenes the Annual General Meeting of Shareholders 2026

Philips convenes the Annual General Meeting of Shareholders 2026 March 23, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as m...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch